We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current NRO market cap is 1.12B. The company's latest EPS is EUR 2.0351 and P/E is 22.65.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 511.49M | 526.03M | 582.1M | 668.38M | 743.71M |
| Operating Income | 53.21M | 56.23M | 67.47M | 81.76M | 84.24M |
| Net Income | 30.8M | 30.92M | 37.71M | 44.24M | 49.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 510.14M | 549.85M | 567.82M | 616.22M | 674.25M |
| Total Liabilities | 182.82M | 190.83M | 214.9M | 240.64M | 266.34M |
| Total Equity | 327.32M | 359.03M | 352.92M | 375.58M | 407.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 61.32M | 67.29M | 64.5M | 54.97M | 72.08M |
| Investing | -8.15M | -8.01M | -10.62M | -12.26M | -21.57M |
| Financing | -9.36M | -11.05M | -55.43M | -36.08M | -27.06M |
| Market Cap | 1.12B |
| Price to Earnings Ratio | 22.65 |
| Price to Sales Ratio | 1.5 |
| Price to Cash Ratio | 3.76 |
| Price to Book Ratio | 2.74 |
| Dividend Yield | 2.39% |
| Shares Outstanding | 24.28M |
| Average Volume (1 week) | 2.2k |
| Average Volume (1 Month) | 4.9k |
| 52 Week Change | 22.61% |
| 52 Week High | 48.15 |
| 52 Week Low | 33.45 |
| Spread (Intraday) | 0.2 (0.43%) |
| Company Name | Neurones |
| Address |
immeuble le clemenceau 1 nanterre, hauts-de-seine 92024 |
| Website | https://www.neurones.net |
| Industry | computer programming service (7371) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
